Trial intelligence / Profile preview

Duloxetine vs paroxetine for major depressive disorder

CTR20140375Phase 2Suspended

Sponsor
Lifecare Neuro
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of duloxetine in major depressive disorder (MDD), sponsored by Lifecare Neuro. Started May 2014; status: suspended.

02

Drugs

duloxetine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on CTR20140375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call